[1]
|
http://en.wikipedia.org/wiki/Jeddah
|
[2]
|
Aarestrup, F.M., Wegener, H.C. and Collignon, P. (2008) Resistance in Bacteria of the Food Chain: Epidemiology and Control Strategies. Expert Review of Anti-Infective Therapy, 6, 733-750. http://dx.doi.org/10.1586/14787210.6.5.733
|
[3]
|
Maragakis, L.L. and Perl, T.M. (2008) Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options. Clinical Infectious Diseases, 46, 1254-1263. http://dx.doi.org/10.1086/529198
|
[4]
|
Walsh, C.T. (2003) Antibiotics: Actions, Origins, Resistance. American Society for Microbiology, Washington DC.
http://dx.doi.org/10.1128/9781555817886
|
[5]
|
Levy, S.B. and Marshall, B. (2004) Antibacterial Resistance Worldwide: Causes, Challenges and Responses. Nature Medicine, S122-S129. http://dx.doi.org/10.1038/nm1145
|
[6]
|
Atkinson, B.A. and Lorian, V. (1984) Antimicrobial Agent Susceptibility Patterns of Bacteria in Hospitals from 1971 to 1982. Journal of Clinical Microbiology, 20, 791-796.
|
[7]
|
von Baum, H. and Marre, R. (2005) Antimicrobial Resistance of Escherichia coli and Therapeutic Implications. International Journal of Medical Microbiology, 295, 503-511. http://dx.doi.org/10.1016/j.ijmm.2005.07.002
|
[8]
|
Kronvall, G.A. (2010) Antimicrobial Resistance 1979-2009 at Karolinska Hospital, Sweden: Normalized Resistance Interpretation during a 30-Year Follow-Up on Staphylococcus aureus and Escherichia coli Resistance Development. APMIS, 118, 621-639. http://dx.doi.org/10.1111/j.1600-0463.2010.02660.x
|
[9]
|
Blaettler, L., Mertz, D., Frei, R., Elzi, L., Widmer, A.F., Battegay, M., et al. (2009) Secular Trend and Risk Factors for Antimicrobial Resistance in Escherichia coli Isolates in Switzerland 1997-2007. Infection, 37, 534-539.
http://dx.doi.org/10.1007/s15010-009-8457-0
|
[10]
|
Naas, T., Nordmann, P., Vedel, G. and Poyart, C. (2005) Plasmid-Mediated Carbapenem-Hydrolyzing Beta-Lactamase KPC in a Klebsiella pneumoniae Isolate from France. Antimicrobial Agents and Chemotherapy, 49, 4423-4424.
http://dx.doi.org/10.1128/AAC.49.10.4423-4424.2005
|
[11]
|
Schwaber, M.J. and Carmeli, Y. (2008) Carbapenem-Resistant Enterobacteriaceae: A Potential Threat. JAMA, 300, 2911-2913. http://dx.doi.org/10.1001/jama.2008.896
|
[12]
|
Won, S.Y., Munoz-Price, L.S., Lolans, K., Hota, B., Weinstein, R.A. and Hayden, M.K. (2011) Emergence and Rapid Regional Spread of Klebsiella pneumonia Carbapenemase-Producing Enterobacteriaceae. Clinical Infectious Diseases, 53, 532-540. http://dx.doi.org/10.1093/cid/cir482
|
[13]
|
Sanchez, G.V., Master, R.N., Clark, R.B., Fyyaz, M., Duvvuri, P., Ekta, G. and Bordon, J. (2013) Klebsiella pneumoniae Antimicrobial Drug Resistance, United States, 1998-2010. Emerging Infectious Diseases, 19, 133-136.
http://dx.doi.org/10.3201/eid1901.120310
|
[14]
|
Obritsch, M.D., Fish, D.N., MacLaren, R. and Jung, R. (2005) Nosocomial Infections Due to Multidrug-Resistant Pseudomonas aeruginosa: Epidemiology and Treatment Options. Pharmacotherapy, 25, 1353-1364
|
[15]
|
Go, E.S., Urban, C., Burns, J., Kreiswirth, B., Eisner, W., Mariano, N., et al. (1994) Clinical and Molecular Epidemiology of Acinetobacter Infections Sensitive Only to Polymyxin B and Sulbactam. Lancet, 344, 1329-1332.
http://dx.doi.org/10.1016/S0140-6736(94)90694-7
|
[16]
|
Butler, M.S., Blaskovich, M.A. and Cooper, M.A. (2013) Antibiotics in the Clinical Pipeline in 2013. The Journal of Antibiotics, 66, 571-591. http://dx.doi.org/10.1038/ja.2013.86
|
[17]
|
Wagenlehner, F.M., Weidner, W. and Naber, K.G. (2007) Pharmacokinetic Characteristics of Antimicrobials and Optimal Treatment of Urosepsis. Clinical Pharmacokinetics, 46, 291-305.
http://dx.doi.org/10.2165/00003088-200746040-00003
|
[18]
|
Livermore, D.M., Nichols, T., Lamagni, T.L., Potz, N., Reynolds, R. and Duckworth, G. (2003) Ciprofloxacin-Resistant Escherichia coli from Bacteraemias in England; Increasingly Prevalent and Mostly from Men. Journal of Antimicrobial Chemotherapy, 52, 1040-1042. http://dx.doi.org/10.1093/jac/dkg479
|
[19]
|
Mavroidi, A., Miriagou, V., Liakopoulos, A., Tzelepi, Ε., Stefos, A., Dalekos, G.N. and Petinak, E. (2012) Ciprofloxacin-Resistant Escherichia coli in Central Greece: Mechanisms of Resistance and Molecular Identification. BMC Infectious Diseases, 12, 371. http://www.biomedcentral.com/1471-2334/12/371
|
[20]
|
Manchanda, V., Sanchaita, S. and Singh, N.P. (2010) Multidrug Resistant Acinetobacter. Journal of Global Infectious Diseases, 2, 291-304. http://dx.doi.org/10.4103/0974-777X.68538
|
[21]
|
Obritsch, M.D., Fish, D.N., MacLaren, R. and Jung, R. (2004) National Surveillance of Antimicrobial Resistance in Pseudomonas aeruginosa Isolates Obtained from Intensive Care Unit Patients from 1993 to 2002. Antimicrobial Agents and Chemotherapy, 48, 4606-4610. http://dx.doi.org/10.1128/AAC.48.12.4606-4610.2004
|
[22]
|
Raja, N.S. and Singh, N.N. (2007) Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas aeruginosa in a Tertiary Care Hospital. Journal of Microbiology, Immunology and Infection, 40, 45-49.
|
[23]
|
Manno, G., Cruciani, M., Romano, L., Scapolan, S., Mentasti, M., Lorini, R., et al. (2005) Antimicrobial Use and Pseudomonas aeruginosa Susceptibility Profile in a Cystic Fibrosis Centre. International Journal of Antimicrobial Agents, 25, 193-197. http://dx.doi.org/10.1016/j.ijantimicag.2004.11.009
|
[24]
|
Panlilio, A.L., Culver, D.H., Gaynes, R.P., Banerjee, S., Henderson, T.S., Tolson, J.S., et al. (1992) Methicillin Resistant Staphylococcus aureus in US Hospitals, 1975-1991. Infection Control and Hospital Epidemiology, 13, 582-586.
http://dx.doi.org/10.2307/30148460
|
[25]
|
Mekviwattanawong, S., Srifuengfung, S., Chokepaibulkit, K., Lohsiriwat, D. and Thamlikitkul, V. (2006) Epidemiology of Staphylococcus aureus Infections and the Prevalence of Infection Caused by Community Acquired Methicillin-Resistant Staphylococcus aureus in Hospitalized Patients at Siriraj Hospital. Journal of the Medical Association of Thailand, 89, S106-S117.
|
[26]
|
Diekema, D.J., Pfaller, M.A., Schmitz, F.J., Smayevsky, J., Bell, J., Jones, R.N., et al. (2001) Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases, 32, S114-S132.
|
[27]
|
Thamlikitkul, V., Jintanothaitavorn, D., Sathitmethakul, R., Vaithayaphichet, S., Trakulsomboon, S. and Danchaivijitr, S. (2001) Bacterial Infections in Hospitalized Patients in Thailand in 1997 and 2000. Journal of the Medical Association of Thailand, 84, 666-673.
|
[28]
|
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. and Tenover, F.C. (1997) Methicillin-Resistant Staphylococcus aureus Clinical Strain with Reduced Vancomycin Susceptibility. Journal of Antimicrobial Chemotherapy, 40, 135-136. http://dx.doi.org/10.1093/jac/40.1.135
|
[29]
|
Ploy, M.C., Grelaud, C., Martin, C., de Lumley, L. and Denis, F. (1998) First Clinical Isolate of Vancomycin-Inter mediate Staphylococcus aureus in a French Hospital. Lancet, 351, 1212.
http://dx.doi.org/10.1016/S0140-6736(05)79166-2
|
[30]
|
Hofmann, J., Cetron, M.S., Farley, M.M., Baughman, W.S., Facklam, R.R., Elliott, J., Deaver, K.A. and Breiman, R.F. (1995) Prevalence of Drug-Resistant Streptococcus pneumoniae in Atlanta. The New England Journal of Medicine, 333, 481-486. http://dx.doi.org/10.1056/NEJM199508243330803
|